Continuum Advisory’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Buy |
36,587
+36,560
| +135,407% | +$4.6M | 0.55% | 42 |
|
|
2025
Q1 | $2.99K | Hold |
27
| – | – | ﹤0.01% | 1226 |
|
|
2024
Q4 | $3.69K | Sell |
27
-6
| -18% | -$819 | ﹤0.01% | 1211 |
|
|
2024
Q3 | $4.06K | Buy |
33
+10
| +43% | +$1.23K | ﹤0.01% | 1218 |
|
|
2024
Q2 | $3.17K | Hold |
23
| – | – | ﹤0.01% | 1190 |
|
|
2024
Q1 | $3.21K | Buy |
+23
| New | +$3.21K | ﹤0.01% | 1167 |
|